MedicaidCoverageMedium impact
Newsletter Vol. 10, No. 48
New Jersey Medicaid·NJ · Pharmacy, Infectious Disease·Medical Policy
Effective date
Jul 1, 2000
We identified it
Jun 20, 2026
Summary
Effective July 1, 2000, Work First New Jersey/General Assistance (WFNJ/GA) beneficiaries diagnosed with HIV/AIDS must enroll in the AIDS Drugs Distribution Program (ADDP) for coverage of specific antiretroviral medications. During the enrollment transition period, pharmacies should continue receiving reimbursement for ADDP-covered HIV/AIDS drugs, and Error Code 402 will be converted to an informational message directing patients to enroll in ADDP rather than denying claims.
Action Required
By July 1, 2000: Billing and pharmacy teams must (1) Update billing system to change Error Code 402 from a claim denial to an informational message for WFNJ/GA beneficiaries; (2) Continue processing and reimbursing claims for ADDP-covered HIV/AIDS drugs (thymidine nucleosides, thymidine analogs, protease inhibitors, nucleoside analog reverse transcriptase inhibitors, non-nucleoside reverse transcriptase inhibitors, carbocyclic nucleoside analogs, purine nucleoside analogs of deoxyadenosine, and primidine nucleoside analogs) without denial; (3) Assist WFNJ/GA patients in enrolling in ADDP by providing applications or directing them to General AIDS Hotline (800-624-2377) or ADDP General Information Number (609-588-7038); (4) Maintain inventory of ADDP applications if feasible. Failure to support the enrollment transition may delay patient access to medications during the implementation period.